The activity of MHC class II promoters depends upon conserved regulatory signals one of which, the extended X-box, contains In its X 2 subreglon a sequence related to the cAMP response element, CRE and to the TPA response element, TRE. Accordingly, X 2 is recognized by the AP-1 factor and by other c-Jun or c-Fos containing heterodlmers. We report that the X-box dependent promoter activity of the HLA-DQA1 gene Is down-modulated by an array of DNA elements each of which represented twice either in an invertedly or directly repeated orientation. In this frame, we describe a nuclear binding factor, namely DBF, promiscuously Interacting with two of these additional signals, 8 and a, and with a portion of the X-box, namely the X-core, devoid of X 2 . The presence of a single factor recognizing divergent DNA sequences was Indicated by the finding that these activities were coeluted from a heparin-Sepharose column and from DNA affinity columns carrying different DNA binding sites as ligands. Competition experiments made with oligonucleotides representing wild type and mutant DNA elements showed that each DNA element specifically Inhibited the binding of the others, supporting the contention that DBF is involved in recognition of different targets. Furthermore, we found that DBF also exhibits CRE/TRE binding activity and that this activity can be competed out by addition of an excess of a, 8 and X-core oligonucleotides. Anti-Jun peptide and anti-Fos peptide antibodies blocked not only the binding activity of DBF, but also its X-core and a binding; this blockade was removed by the addition of the Jun or Fos peptides against which the antibodies had been raised. In vitro synthesized Jun/Fos was able to bind to all these boxes, albeit with seemingly different affinities. The cooperativity of DBF interactions may explain the modulation of the X-box dependent promoter activity mediated by the accessory DNA elements described here.
INTRODUCTION
The expression of MHC class II genes is controlled by composite tissue-specific promoters encompassing conserved regulatory sites, whose function has been extensively studied [1, 2] . One of these sites is a signal known as the X-box, whose deletion abolishes class II gene activity. Different subregions of the Xbox have been identified; one of them, namely X 2 , codes for a degenerated binding site of the AP-1 factor [1, 2] . The latter, a Jun/Fos heterodimer, binds to the cyclic-AMP response element (CRE) and to the closely related 12-o-tetradecanoyl phorbol 13-acetate response element (TRE) [3, 4] . In addition, broad recognition of divergent CRE or TRE sites has been observed; relaxed specificity of AP-1 is attributed to flexible DNA sequence recognition by the Jun/Fos heterodimer [5] [6] [7] [8] . For example the TGGGTCA sequence, also containing the half palindrome estrogen responsive element (ERE) is recognized by the AP-1 complex by virtue of its limited divergence from the TRE/CRE sequences [6] . In this case association of Jun with other members of the Jun/Fos family, such as the mXBP/CRE-BP2 protein, influences the selectivity for the binding site [7] .
We report here that relatedness to the canonical AP-1 recognition site is not a stringent requirement for the binding of certain MHC class JJ regulatory elements to DBF, a nuclear factor exhibiting AP-1 like activity. We have studied the ability of this factor to form complexes with the portion of the X-box not including the CRE/TRE sequences (hereinafter, the X-core) and with other controlling elements (a, 8) derived from the promoter of a MHC class JJ gene, HLA-DQA1 [9; see ref. 1 
for a review].
Although the function of the X-box has been studied in detail [1 and refs. therein] , less is known about the role of the other two boxes [9] ; we have previously observed that the a-box (GAA-GTAGAAA) is similar to the interferon a response element, VRE [10] , while the 5-box (TGGGGTCA) resembles the sterol dependent repressor element, SDR [11] and the ovalbumin estrogen-responsive element, ERE (TGGGTCA) [6] . We report now that a short promoter region encompassing both a and 8 has a negative effect on the transcription of the HLA-DQA1 promoter. We show that a, 8 and the X-core form a complex with DBF and that formation of this complex is inhibited by the addition of an excess of an oligonucleotide representing the AP-1 binding site or of anti-Jun or anti-Fos antibodies. The fact that no sequence homology is apparently shared by the AP-1 site and by the Xcore and the a-boxes makes the co-recognition of these elements by DBF rather intriguing. These observations, however, are by no means unprecedented. It was in fact recently reported that the NF-AT factor contains Jun and Fos and that the 11-2 AP-1 and the metallothionein AP-1 oligonucleotides are able to inhibit a complex formed by the NF-AT factor with its cognate binding site, although the sequence of the latter differs from that of CRE or TRE [12] .
MATERIAL AND METHODS Piasmid construction and CAT assays
The pBLCAT2 and pBLCAT3 vectors [13] were used to study the expression of the chloramphenicol acetyl transferase enzyme under the control of the HLA-DQA1 promoter elements; pBLCAT3 carries a promoterless CAT reporter gene, while pBLCAT2 contains an enhancerless heterologous promoter (TK). Cloning methods and CAT assay protocols were previously described [9] ; primers used for PCR-assisted subcloning of HLA-DQA1 regulatory regions were desumed from known sequence information (9 and ref.s therein). Co-transfection with the pRSV/ac plasmid expressing the luciferase activity from the RSV promoter was used for standardization of the CAT activity expressed in transient transfection assays of HLA-DQA1 promoter constructs [9] .
Preparation of nuclei and gel retardation assays Nuclei from Raji cells were prepared according to a procedure which gives transcriptionally active intact nuclei [14] . Briefly, 3 X10
7 Raji cells grown in RPMI 1640 supplemented with 5% fetal calf serum were harvested, washed twice in 1X PBS and resuspended in 2 ml of buffer B (60 mM KC1, 15m M NaCl, 0.15 mM spermine, 0.5 mM spermidine, 15 mM HEPES pH 7.5, 14 mM /3-mercaptoethanol, 0.3 M sucrose, 0.5 mM EGTA and 2 mM EDTA); 2 ml of buffer B containing 0.1 % NP40 were added (final NP40 concentration: 0.05%) and the mixture was gently pipetted for 1 min on ice. The suspension was then layered onto 5 ml of buffer C (equivalent to buffer B, but containing 30% sucrose) and centrifuged at 2500 rpm at 4°C for 30 min. Nuclear extracts were then obtained by incubating the nuclei in 0.4 ml of buffer E (0.4 M NaCl, 0.5 mM MgCl 2 ; 0.2 mM EDTA, 20 mM HEPES, pH7.9, 25% glycerol, 0.5 mM DTT, 0.5 mM PMSF, 5 ng//d pepstatin) at 4°C for 30 min. The lysed nuclei were then centrifuged for 30 min at 4°C and 14.000 rpm. The supernatant was subdived in small aliquots and stored frozen (-80°C).The total amount of protein extracted by this procedure was equivalent to that observed when the procedure of Dignam et al. [15] was applied (4-12 /tg/10 6 cells), but the amount of AP-1 activity measured by band-shift was 3-5 fold higher than in the standard procedure. Band shift experiments were performed in the presence of 600-900 ng of sonicated E.coli DNA as previously reported [15] ; 2-3 /*g of nuclear proteins and 0.03-0.06 ng of labelled probe (specific activity = 0.5-l.OxlO 5 cpm/ng DNA) were used for each assay. For competition experiments a 200 x excess of unlabelled competitor was added.
Antibodies and antibody competition
Polyclonal antibodies against a thyroglobulin-conjugated peptide from the basic domain of c-Jun (NRIAASKCRKRKLERI) were obtained from CALTAG Laboratories, USA. The peptide used as an immunogen is conserved in c-Jun, JunB and JunD, but is degenerated at several residues in other bZIP family members such as CREB, C/EBP1, CRE-BP1, Fos, etc. [36, 37] . Anti-Fos antisera directed against epitopes from different regions of c-Fos were also obtained from CALTAG. Antisera directed against bacterially produced c-Jun (obtained from G.Spyrou, Paris from F.Blasi, Copenhagen) were also used; these antibodies specifically recognize c-Jun as tested by immunoprecipitation, immunofluorescence and gel shft inhibition [39, 40] . Inhibition of binding by antibodies (1-6 ng per assay) and counterinhibition by peptides (1-3 /ig per assay) was determined as previously reported [6, 12, 16] ; nuclear extracts were preadsorbed for 1 -2 hrs with the antibodies before binding. Antisera from non-immune animals, chicken antisera and irrelevant mAbs were used as controls.
Heparin Sepharose and DNA affinity chromatography A nuclear extract (6 ml, 0.6 /ig//d) from 5 X10 8 cells was loaded at 4°C onto a Heparin-Sepharose column (bed volume = 6 ml) equilibrated with 20 mM HEPES, pH 7.9, 20% glycerol, 0.2 mM EDTA, 0.5 mM DTT, 100 mM KC1, 0.5 mM PMSF. After extensive washing with equilibration buffer, the proteins retained were eluted by adding 10 ml of a 0.1 -1 M KC1 gradient in Tris-HCl pH 7.4. An aliquot of each fraction was tested in bandshift assays. 80X10 6 Raji cells were washed in PBS and resuspended in RPMT1640 medium without methionine, in the absence of fetal calf serum (FCS). After methionine starvation (incubation for 1 hr at 37°C, 5% CO2, the cells were washed again and resuspended at a concentration of 2 X107 cells/ml in the same medium; 0.5 mCi of [35] -S-methionine and 5% FCS were then added. The cell suspension was further incubated for 4 hrs at 37°C and 5% CO2. Nuclei and nuclear extracts were then prepared as described in the Legend to Fig. 1 . 1.2 ml of nuclear extracts (23 X10 6 cpm//xl) were diluted in in buffer A (10 mM Tris-HCl pH 7.4, 1 mM EDTA, 10 mM 0-mercaptoethanol, 0.1% Triton X-100, 0.5 mM MgCl 2 and 100 mM NaCl, final concentration) and incubated at 4°C for 30 min in the presence of 100 ng of sonicated E.coli DNA. The protein solution was then loaded onto a Sepharose 4B column (bed volume = 4 ml) equilibrated with buffer A. The flow-through of this column was subsequently loaded onto a a DNA-or Xcore DNA-affinity column equilibrated with the same buffer in the presence of 100 /tg/ml E.coli DNA. After loading, each column was extensively washed with equilibration buffer before during the proteins retained by the Sepharose 4B, the Xcore/Sepharose and the (j/Sepharose columns by adding to each 8 ml of a 0.2-2 M NaCl gradient in buffer A.
RESULTS

Transient transfection analysis
Previous reports indicated that MHC class II regulated expression of a fused CAT reporter gene can be directed by DNA fragments encompassing the promoter proximal region of the HLA-DQA1 gene [17] . This promoter activity was dependent onto the presence of conserved DNA elements, the X-and Y-boxes [1, 17] ; furthermore, sequences adjacent to the minimal promoter region of this gene appeared to modulate the X-and Y-box dependent promoter expression [17] . To study this aspect, we fused fragments of the HLA-DQA1 promoter, encompassing the X-Y region and part of the flanking sequences, to the CAT gene carried by the promoterless pBLCAT3 vector [13] ; some of the promoter constructs. A EcoRI-BamHI fragment of DNA encompassing the promoter proximal region, the 5'UT/SP exon and the 5' end of the 1st intron of HLA-DQA1 was cloned into the pBLCAT3 plasmid and fused to the CAT gene; the plasmid thus obtained was named 3N7A, when the fragment was inserted in the same direction of transcription as CAT, or 3N7B, when it was in the opposite direction [9] . Plasmid 3N9A and 3N9B were obtained by subcloning a partially overlapping fragment into the pBLCAT3 vector (ref. 9 and Fig. 1A ). Transfection into Raji cells and CAT assays were performed as described in ref. 9 ; the pRSVluc plasmid was cotransfected as an internal standard. Equimoiar amounts of DNA were used for each assay and multiple independent transfection experiments were run [9] . C: CAT assays of E, S, a and /i-containing constructs. The £, a, 6 and n boxes were added in different combinations to the 3RI fragment; CAT activities are expressed as % of activity (3RI = 100%).
fragments utilized are described in Fig. 1A . Figure IB shows that, although the X-Y region was present in both cases, the expression directed by the fragment cloned in plasmid 3N7A, was significantly higher than that observed when the overlapping 3N9A plasmid was used. These variations were not related to the efficiency of transfection as, on one hand, they were highly reproducible and, on the other, the assays were normalized for the level of co-expression of a co-transfected luciferase gene. The MHC class II promoter dependent activity of these constructs was indicated by the lack of expression observed (data not shown and ref. 9) when the constructs were transfected into RJ2.2.5, a MHC class H-negative transcriptional mutant [18] , Sequence analysis of the region of 3N9A upstream to 3N7A had previously shown [9] that it contains 4 putative boxes for which complete or partial repeats can be found in the vicinity of the X and Y boxes (see also Fig. 1A and Fig. 2B ). Two of these elements, E and /t, were direct repeats, while IT and 6 were invertedly repeated. We prepared DNA constructs in which the minimal promoter region (thus including X and Y, but not most of the surrounding sequences) carried by plasmid 3RI (see Fig. 1A ) was attached to fragments of DNA carrying the four boxes in different combinations (Fig. 1C) . As shown in the Figure, the presence of these boxes reduced the expression directed by the minimal promoter; the effect of the various boxes was additive and the overall reduction was about 70% of the initial activity. A similar experiment was performed by fusing the a, n, 8 and E boxes to the TK promoter of the pBLCAT2 plasmid (data not reported); little (5) or no (a, /t, E) influence onto the basal expression of this heterologous promoter was observed. In conclusion the a, fi, 8 and E boxes appear to reduce preferentially the expression of the X-and Y-box dependent HLA-DQA1 promoter.
Heparin chromatography and DNA affinity chromatography
Preliminary experiments indicated that the DNA elements discussed above were able to form complexes with nuclear extracts prepared from transcriptionally active Raji cell nuclei (see Methods). In this section we shall report data concerning the binding of nuclear factors to the invertedly repeated a and 5 sequences; those concerning p. and E will be discussed elsewhere. The relevant portion of the sequences used for binding or for competition are summarized in Fig. 2A ; all oligonucleotides used as probes were 16-19 bp long; their localization inside the HLA-DQA1 promoter is reported in Fig. 2B . To study the binding activities of Raji directed against the HLA-DQA1 promoter elements, nuclear extracts were partially purified upon adsorption onto a heparin Sepharose column by fractionation with increasing salt concentrations (Fig. 3A) . All the fractions were tested for their ability to bind to labelled a, 8 and X-core oligonucleotides. As shown in Fig. 3B and C for the X-core and for a, the peak of binding activity against these two regulatory sequences was recovered in the same fractions (16) (17) (18) (19) (20) . A second complex was formed with a ( Fig. 3C ) after elution; diis activity, usually not observed when using freshly prepared nuclear extracts, appears to accumulate during the time in aged preparations even in the presence of protease inhibitors. Fractions that bind to a and X-core also bind to the 8 probe (not shown). Cross-competition experiments demonstrated that formation of the upper tend between the partially purified activity and labelled a was inhibited by addition of 200 x molar excess not only of unlabelled probe, but also of unlabelled X-core oligonucleotide (Fig. 3D) ; conversely the lower band was more resistant to [11] and to the OVA estrogen response ERE (TGGGT-CA) [6] ; the a element is similar to the interferon a viral response element VRE (GAANNGAAAG/COT) [10] . The X-core is part of the HLA-DQil X-box [1, 5] ; X 2 is a subregion of X that binds AP-1 [1, 5] . Nucleotides of CRE and AP-1 conserved in X, a and 5 are depicted as bold, underlined characters; small letters indicate nucleotide substitutions introduced into a to obtain a\, o2 and a3. B: Relative localization of HLA-DQA1 proximal and distal promoter elements. Numbers refer to the posisition of the boxes relative to the transcriptional start site. 6 is present in two inverted copies; a complete copy of a is present in the distal region of the promoter whereas an incomplete inverted copy of it partially overlaps Y.
competition by the X-core. Moreover, the binding to labelled X-core was inhibited by excess a or 8 (not shown); a more detailed competition analysis is presented in the following section.
To further distinguish if all the activities considered are carried by the same factor or by factors co-migrating in the chromatographic system used, we asked whether each activity could, or could not, be separately recovered by DNA affinity chromatography through Sepharose 4B columns activated with oligonucleotides corresponding to different binding sites. To this end, the X-core and the o* oligonucleotides were separately coupled to Sepharose 4B. Nuclear extracts from [35] -S methionine labelled Raji cells were exhaustively pre-cleared by adsorption onto uncoupled Sepharose 4B until all the proteins that were able to bind to the Sepharose 4B backbone were adsorbed. After elimination of this background, the flow-through proteins were analyzed by DNA affinity chromatography in conditions suppressing the aspecific binding (see Methods). A peak of X-binding activity was eluted from the X-column (fractions X8 to X10, shown in Fig. 4A ) and a peak of a-binding activity was eluted from the a-column (fractions a 10 and o l2 , Fig. 4B ). The activity recovered from the a-column was in turn tested for ability to bind to the labelled X-probe and viceversa; fractions selected solely on the basis of their ability to recognize the ff-box were also able to interact with the X-core (Fig. 4C,  lanes i and j) ; the reverse was also true (not shown). The fractions from the two different columns were analyzed by SDS/PAGE and monitored by autoradiography (Fig. 4D) . As care had been taken to suppress aspecific binding to either the Sepharose backbone or to the immobilized DNA (see Methods), we believe that the proteins eluted were specifically retarded by the affinity ligands. Several protein species were detectable in the fractions of both columns; in particular, a -46 KDa protein is present in fractions X 8 and a 10 , both exhibiting binding activity. The presence of at least one band exhibiting the same electrophoretic behaviour further suggests that the X-core and the a binding activity may have common components. Bands typical of each ligand may instead be an indication of the formation of weaker element-specific complexes not detectable in conventional bandshift assays, but enriched by affinity chromatography. Subsequently, the 8 box was used as a probe to test the binding activity of these preparations. Also in this case the active fractions reacted with the probe (not shown).
In conclusion, the finding that a, 8 and the X-core binding activities co-migrate through a heparin-Sepharose column and can be co-purified on different DNA-affinity chromatography columns indicates that the same factor, hereinafter DBF, recognizes all these elements; this conclusion is also supported by the cross-competition experiments that have been presented in this section and by others that will be presented in the next section.
Jun/Fos activity of DBF
We reported in the previous paragraph that the same factor, DBF, binds to the a, 8 and X-core elements. We also presented preliminary evidence from cross-competition experiments indicating that each box competed for the binding of the others to DBF. As the sequence of one of these oligonucleotides, 5, appears to be related to the ovalbumin estrogen-responsive elements (ERE), in turn recognized by the Jun/Fos complex [6] , we asked whether oligonucleotides representing the CRE or TRE binding sites were able to compete with the binding of the Xcore, a and 5 elements. As shown in Fig. 5A , a 200-fold molar excess of the CRE oligonucleotide inhibits the binding of the Xcore element (lane b). As previously mentioned, the binding of the X-core to DBF is also inhibited in the presence of a 200-fold molar excess of a (Fig. 5A, lane c) ; to determine the specificity of this inhibition, different mutations were introduced into the competing oligonucleotide; we found that the a\ mutant (carrying the G to T mutation indicated in Fig. 2 ) was unable to compete with the binding to the X-core oligonucleotide, when used at the same molar excess then a Qane d); conversely the al and the <J3 mutants, carrying base changes at other positions (lanes e and f) had no effect. In addition, we examined the ability of unrelated oligonucleotides, namely AB and N, designed after the prokaryotic promoter consensus sequence, to compete for the binding of the others: no competition was observed with these oligonucleotides (Fig. 5B) . We also found that the X-core was able to block the formation of a complex between the nuclear factor and a labelled oligonucleotide carrying the CRE binding site (Fig. 5C, lane b) . The ability to compete with this binding also extends to 8 and a (lanes c and d respectively) ; on the contrary, the N oligonucleotide was, as expected, ineffective Qane a). Furthermore, the Jun/Fos-like activity was not inhibited by the a\ mutant oligonucleotide, although it was inhibited by wild type a (Fig. 5D ) and by dl and a3 (not shown). In conclusion, these competition experiments further indicated that the X-core, a and 8 oligonucleotides, although not exhibiting a significant degree of sequence similarity were all capable of binding to the same factor. Furthermore, they apparently share with CRE a binding site onto DBF, thus suggesting that c-Jun and c-Fos may be implicated in these interactions. We analyzed the effect of anti-Jun and anti-Fos antisera [6, 15, 16] onto the ability of the different boxes to form a complex with nuclear extracts. These antisera were directed against peptides carrying specific epitopes of the two factors; antibodies raised by immunization against peptides derived from less conserved regions have been previously shown to allow discrimination among members of different bZIP families (12, 16, 35) . In this case, comparison of the primary sequence of aJun-derived 16-mer peptide used as an immunogen with that of the corresponding region of other factors showed that the peptide is conserved in JunD and slightly less conserved in JunB (two amino acid residues changes); a greater divergence (at 6 residues or more) is observed in CREB, Fos, FosB, Fra-1, C/EBP and CRE-BP1 [37, 36] . The anti-Jun antiserum raised against the 16-mer peptide was able to discriminate among peptides having this level of degeneration as, for example, it was unable to cross-react with a corresponding Fos peptide. As shown in Fig. 6A , in the presence of this mono-specific anti-Jun antiserum the upper complex formed with the CRE probe was completely abolished, whereas the faster migrating complex was more resistant [6, 15, 16] ; for comparison the upper complex was unaffected by the presence of a large excess (6.5-fold) of control sera. An epitope specific anti-Fos antibody having similar properties was used with the same results. The effect of these anti-Jun and anti-Fos reagents was then tested onto the binding of labelled X-core, 5 or a to the nuclear factor; complete inhibition of the binding to the X-core, 8 or a was observed; on the contrary the presence of control sera did not interfere with the binding, thus indicating that the effect of the antibodies was specific (Fig. 6B and C) . The specificity of the inhibition was further investigated by titrating the anti-Jun antibody (Fig. 6) or the antiFos antibody (not shown) with an excess of the peptide that had been used as an antigen to raise the respective antiserum. As Figure 6D shows for the Jun peptide, each peptide competed with its cognate antibody and abolished the inhibition of the binding to the X-core element observed with the antibody alone. A similar inhibition was obtained when the a and 5 boxes were used as probes (not shown). Antisera directed against other determinants of either Jun or Fos were used to confirm these findings (data not shown); we found that Jun-specific antisera raised against the bacterially expressed protein [39, 40] fully blocked binding of nuclear extracts to the probes analyzed here. In addition other monospecific anti-Fos antisera, directed against domains of the Fos protein other than the DNA binding domain also caused either inhibition or supershift of the bands. These data support the conclusion that the factors of the nuclear extracts responsible for the binding to these boxes are antigenically related to Jun/Fos.
To assess directly the ability of bona fide Jun/Fos to form complexes with X-core and a, we examined the ability of in vitro synthesized Jun/Fos to form complexes with the corresponding oligonucleotides. Figure 7 shows that reticulocyte lysates do not contain any API or X-core and a binding activity; conversely, when the same reticulocyte lysate was supplemented with the cjun and c-fos mRNA and allowed to translate in vitro Jun and Fos, binding to the an oligonucleotide representing the API site [38] as well as to the X-core and a boxes was observed. As the same amounts of labelled probes having the same specific activity were used in this experiment, the different intensity of the bands found when X-core and a were employed, may reflect a lower binding affinity of in vitro translated Jun/Fos for these boxes. Notably, the API activity found in reticulocyte extracts expressing Jun/Fos was fully inhibited in the presence of anti-Jun and antiFos specific antisera, but not of pre-immune sera (P.Verde, unpublished observations).
DISCUSSION
It is established that the presence of a functional X element in the promoters of the MHC class U genes is essential for their expression in many cell types [1, 2] . The entire sequence of extended X-box of the various MHC class n genes is fairly conserved, although several base changes can be observed. Distinct subregions of X have been defined [1] ; one of these subregions, the X 2 element, is located immediately 3' to the core region (see Fig. 1 ) and contains a sequence which in certain class II genes is more similar to CRE and in others to TRE [5] .
The effect of the X-box on the control of MHC class II gene expression is mediated by the binding to the various subregions of a complex array of proteins [31] ; binding of c-Jun and/or cFos containing heterodimers to X 2 has been found [5, 7] . Cogswell and coworkers [32] reported that Raji nuclear proteins that bound to the W and V element of die HLA-DRA gene promoter were competed for by the distantiy related X-box element; in this case, the positive and negative effects onto the transcription of the HLA-DRA gene mediated by these interactions were attributed to the sharing of sequence homology between X, on one site, and W and V, on the other.The effect of two other elements analyzed in this work, a and 8 is less studied. We reported [9] that two inverted copies of the 5-box are present in the 5'-flanking region of HLA-DQAl; similarly two inverted copies of a, one of which uncomplete, can be found. A copy of a and a copy of <5 are located at 0.7-0.8 kb upstream to the transcriptional start, whereas another is embedded into the promoter proximal region (Fig. 2B) ; in particular, the promoter proximal, uncomplete copy of a is few base pairs downstream to the X-box and overlaps the Y element, a CAAT box required for the expression of MHC class II promoters [1] . The <r-box is similar to the interferon-a response element, VRE [10] and the 5-box is reminiscent of the sterol-dependent repressor element, SDR [11] and of the ovalbumin estrogen responsive element, ERE [6] . Our current data indicate that the activity of the HLA-DQAI minimal promoter is repressed when a second copy of a or 6 is added in cis. In addition, a and <5 seem to have little or no effect onto a heterologous promoter such as the TK promoter, thus suggesting a specific cross-talk with other HLA-DQAI promoter elements.
The presence in Raji cells of a nuclear factor, namely DBF capable of promiscuous binding to the CRE/TRE site, to the a and 8 sequences and to a region of the X-box outside the X 2 subregion of the HLA-DQAI promoter emerged from Binding to a and X-core of DIM»TO translated Jun/Fos. In w/ro transcribed c-jun and c-fos mRNAs were translated in a reticulocyte system (Rede. +Jun/Fos; lanes e-g) and the resulting products were used for DNA binding to an API, X-core or a oligonucleodde; a reticulocyte extract unsupplemented with mRNA (Rede.) was used as a negative control (lanes b-d); nuclear extract proteins (nuc. ex.) from Raji were instead used as a positive control (lane a). In vitro translated Jun/Fos was kindly provided by P.Verde (JJGB, Naples).
chromatographic studies and competition analysis. Experiments based on the use of in vitro translated Jun/Fos indicated that the latter heterodimer was already sufficient to allow binding to sequences as different as these; we cannot presently exclude, however, than other factors concur to the binding activity of DBF.
The cooperative interaction of DBF with adjacent elements may contribute to the fine modulation of the HLA-DQA1 promoter. Instances where convergence of different regulatory systems is mediated by protein-protein interactions between two different receptors [6, 8, [22] [23] [24] [25] [26] 34] , by recognition by different factors of the same binding site or by binding of the same transactivator protein to divergent sequence elements by virtue of flexible contacts with DNA [14, [27] [28] [29] [30] 33] have been encountered. A situation reminiscent of that described here was reported for the ambivalent binding of protein complexes antigenically related to c-myc to distinct DNA sequences [21] and for the interaction of AP-1 with the NF-AT element [12] . In the latter instance, for example, the binding of the T-cell nuclear factor NF-AT to its cognate binding site was inhibited by a AP-1 oligonucleotide derived from either the D-2 promoter or the metallothionein promoter, notwithstanding the fact that the NF-AT binding site and the AP-1 element do not share sequence homology. Furthermore, it was reported that binding of NF-AT to the NF-AT element is inhibited by the addition of anti-Jun and anti-Fos antibodies, thus suggesting that nuclear NF-AT contains Jun and Fos [12] . Here we have reported that antibodies directed against different domains of Jun and Fos or raised against a Jun polypeptide produced in bacteria affect the formation of a complex with the X-core and a box as well as with the CRE site. This finding indicates that the factor responsible for the promiscuous binding observed is antigenically related to Jun/Fos. Because of the properties of the antibodies used, it seems less likely that members of a different bZIP family are implicated, although this cannot be unambiguosly excluded. However, the finding that in vitro translated Jun/Fos is able to bind to these regulatory boxes does not support this possibility.
